Harvard Bioscience (HBIO) Interest Coverage Ratio Growth (1y) (2011 - 2019)
Harvard Bioscience (HBIO) Interest Coverage Ratio Growth (1y) (2011 - 2019) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -75.56% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | - |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -65.15% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -119.42% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | - |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | - |
| 10 | Harvard Bioscience | 26.17 Mn | 19.07 Mn | 12.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | -265.89% |
| Jun 30, 2019 | 164.33% |
| Mar 31, 2019 | 93.97% |
| Dec 31, 2018 | -44.97% |
| Sep 30, 2018 | 129.58% |
| Jun 30, 2018 | 82.76% |
| Mar 31, 2018 | 34.05% |
| Dec 31, 2017 | 128.52% |
| Sep 30, 2017 | 64.21% |
| Jun 30, 2017 | 67.98% |
| Mar 31, 2017 | -59.34% |
| Dec 31, 2016 | -1,414.39% |
| Sep 30, 2016 | -51.77% |
| Jun 30, 2016 | -1,113.47% |
| Mar 31, 2016 | 73.99% |
| Dec 31, 2015 | -93.81% |
| Sep 30, 2015 | -163.72% |
| Jun 30, 2015 | -93.43% |
| Mar 31, 2015 | -202.90% |
| Dec 31, 2014 | 386.42% |